Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control
A Randomized Controlled Trial of Intraoperative Chemical Splanchnicectomy for Patients With Resected Pancreatobiliary Malignancies
Status: Enrolling
Updated:  4/23/2018
Indiana University
mi
from
Indianapolis, IN
Surgery Plus Celiac Nerve Block for Long-term Pancreatic Cancer Pain Control
A Randomized Controlled Trial of Intraoperative Chemical Splanchnicectomy for Patients With Resected Pancreatobiliary Malignancies
Status: Enrolling
Updated: 4/23/2018
Indiana University
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated:  4/23/2018
Southeastern Medical Oncology Center - Goldsboro
mi
from
Goldsboro, NC
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated: 4/23/2018
Southeastern Medical Oncology Center - Goldsboro
mi
from
Goldsboro, NC
Click here to add this to my saved trials
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated:  4/23/2018
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated: 4/23/2018
Comprehensive Cancer Center of Wake Forest University
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated:  4/23/2018
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Wexner Medical Center
mi
from
Columbus, OH
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated: 4/23/2018
Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Wexner Medical Center
mi
from
Columbus, OH
Click here to add this to my saved trials
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated:  4/23/2018
Fletcher Allen Health Care-Medical Center
mi
from
Burlington, VT
Telephone-Based Intervention in Increasing Adherence to Adjuvant Hormonal Therapy in Patients With Breast Cancer
Increasing Adherence to Adjuvant Hormonal Therapy Among Breast Cancer Patients: Phase 2 - Pilot Test of Intervention for Feasibility
Status: Enrolling
Updated: 4/23/2018
Fletcher Allen Health Care-Medical Center
mi
from
Burlington, VT
Click here to add this to my saved trials
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Status: Enrolling
Updated:  4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Status: Enrolling
Updated: 4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Status: Enrolling
Updated:  4/23/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Phase II Trial of Dasatinib in Patients With Isocitrate Dehydrogenase (IDH)-Mutant Advanced Intrahepatic Cholangiocarcinoma
Status: Enrolling
Updated: 4/23/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
A Phase II Neoadjuvant Trial of Sunitinib Malate (SU011248) Plus Hormonal Ablation for Patients Who Have High Risk Localized Prostate Cancer and Will Undergo Prostatectomy
Status: Enrolling
Updated:  4/23/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy
A Phase II Neoadjuvant Trial of Sunitinib Malate (SU011248) Plus Hormonal Ablation for Patients Who Have High Risk Localized Prostate Cancer and Will Undergo Prostatectomy
Status: Enrolling
Updated: 4/23/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated:  4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated: 4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated:  4/23/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated: 4/23/2018
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated:  4/23/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Patients With Biliary Tract and Gallbladder Cancer
Phase II Study of Capecitabine, Oxaliplatin, Bevacizumab and Radiation Therapy in Biliary Tract and Gallbladder Cancer
Status: Enrolling
Updated: 4/23/2018
Beth Israel Deaconess Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
Status: Enrolling
Updated:  4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
A Pilot Study of Optical Molecular Imaging for Percutaneous Biopsy of Hepatocellular Carcinoma Using Indocyanine Green
Status: Enrolling
Updated: 4/23/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Stereotactic Radiation Therapy, Nelfinavir Mesylate, Gemcitabine Hydrochloride, Leucovorin Calcium, and Fluorouracil in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase 1 Study of Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir as Part of a Neoadjuvant Regimen in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Status: Enrolling
Updated:  4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Effects of Essential Amino Acid Intake on Net Protein Synthesis in Weight-losing Non-small Cell Lung Cancer Patients
Status: Enrolling
Updated: 4/24/2018
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Status: Enrolling
Updated:  4/24/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Status: Enrolling
Updated: 4/24/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Status: Enrolling
Updated:  4/24/2018
Montefiore Medical Center
mi
from
Bronx, NY
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Improving a Bayesian Model's Survival Estimates in Patients Needing Surgery for Bone Metastases
Status: Enrolling
Updated: 4/24/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (COACH)
Status: Enrolling
Updated:  4/24/2018
Johns Hopkins Center to Reduce Cancer Disparities
mi
from
Baltimore, MD
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors
Evaluating Coaches of Older Adults for Cancer Care and Health Behaviors (COACH)
Status: Enrolling
Updated: 4/24/2018
Johns Hopkins Center to Reduce Cancer Disparities
mi
from
Baltimore, MD
Click here to add this to my saved trials
Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Combination Chemotherapy With or Without Oregovomab Followed by Stereotactic Body Radiation Therapy and Nelfinavir Mesylate in Treating Patients With Locally Advanced Pancreatic Cancer
A Phase II Study of Neoadjuvant Chemotherapy With and Without Immunotherapy to CA125 (Oregovomab) Followed by Hypofractionated Stereotactic Radiotherapy and Concurrent HIV Protease Inhibitor Nelfinavir in Patients With Locally Advanced Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Univ of Nebraska Med Ctr
mi
from
Omaha, NE
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
Indiana University Medical Center
mi
from
Indianapolis, IN
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Indiana University Medical Center
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Virginia Mason Medical Center
mi
from
Seattle, WA
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
CUB Hopital Erasme
mi
from
Brussels,
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
CUB Hopital Erasme
mi
from
Brussels,
Click here to add this to my saved trials
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated:  4/24/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
Randomized Controlled Trial Comparing Covered and Uncovered Biliary Self Expanding Metal Stents (SEMS) for Pre-operative Drainage During Neoadjuvant Therapy in Patients With Pancreatic Cancer
Status: Enrolling
Updated: 4/24/2018
University of Pittsburgh Medical Center
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Vaccine Therapy in Treating Patients With Kidney Cancer
Injection of Renal Cell Carcinoma Patients With Human and Mouse Prostate Specific Membrane Antigen (PSMA) DNA: A Phase I Trial to Assess Safety and Immune Response
Status: Enrolling
Updated:  4/24/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Vaccine Therapy in Treating Patients With Kidney Cancer
Injection of Renal Cell Carcinoma Patients With Human and Mouse Prostate Specific Membrane Antigen (PSMA) DNA: A Phase I Trial to Assess Safety and Immune Response
Status: Enrolling
Updated: 4/24/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers
Utilizing the Arts to Improve Health, Resilience, and Well-Being in Individuals With Cancer and Their Caregivers: A Feasibility Study
Status: Enrolling
Updated:  4/24/2018
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Utilizing the Arts to Improve Health, Resilience, and Well-Being Among Cancer Patients and Their Caregivers
Utilizing the Arts to Improve Health, Resilience, and Well-Being in Individuals With Cancer and Their Caregivers: A Feasibility Study
Status: Enrolling
Updated: 4/24/2018
Cleveland Clinic, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated:  4/24/2018
University of Colorado Hospital
mi
from
Denver, CO
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated: 4/24/2018
University of Colorado Hospital
mi
from
Denver, CO
Click here to add this to my saved trials
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated:  4/24/2018
H. Lee Moffitt Concer Center and Research Institute
mi
from
Tampa, FL
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated: 4/24/2018
H. Lee Moffitt Concer Center and Research Institute
mi
from
Tampa, FL
Click here to add this to my saved trials
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated:  4/24/2018
Roswell Park Cancer Center
mi
from
Buffalo, NY
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated: 4/24/2018
Roswell Park Cancer Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated:  4/24/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
A Phase 1 Study of S-3304 in Patients With Solid Tumors
A Phase 1 Study of S-3304 in Patients With Solid Tumors
Status: Enrolling
Updated: 4/24/2018
Cleveland Clinic Foundation
mi
from
Cleveland, OH
Click here to add this to my saved trials
Partnership for Healthy Seniors
Cancer Prevention and Treatment Among African American Older Adults: Screening Trial
Status: Enrolling
Updated:  4/24/2018
Bloomberg School of Public Health
mi
from
Baltimore, MD
Partnership for Healthy Seniors
Cancer Prevention and Treatment Among African American Older Adults: Screening Trial
Status: Enrolling
Updated: 4/24/2018
Bloomberg School of Public Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated:  4/25/2018
University Hospitals of Cleveland
mi
from
Cleveland, OH
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated: 4/25/2018
University Hospitals of Cleveland
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated:  4/25/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated: 4/25/2018
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated:  4/25/2018
Baylor Research Institute
mi
from
Dallas, TX
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated: 4/25/2018
Baylor Research Institute
mi
from
Dallas, TX
Click here to add this to my saved trials
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated:  4/25/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer
A Phase II Multi-Center Study of Concomitant Cetuximab and Cisplatin With Re-Irradiation Using Intensity-Modulated Radiotherapy in Patients With Recurrent Squamous Cell Carcinoma of the Head-and-Neck
Status: Enrolling
Updated: 4/25/2018
Medical College of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated:  4/25/2018
National Cancer Institute
mi
from
Bethesda, MD
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated: 4/25/2018
National Cancer Institute
mi
from
Bethesda, MD
Click here to add this to my saved trials
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan-Kettering
mi
from
New York, NY
Click here to add this to my saved trials
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated:  4/25/2018
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Sodium Fluoride (NaF) Positron Emission Tomography/Computed Tomography (PET/CT) in Patients With Metastatic Castrate-resistant Prostate Cancer (CRPC) With Microtubule Directed Chemo or AR-directed Therapy
NaF PET/CT Repeatability, Responsiveness, and Response Assessment in Patients With Metastatic Castrate-resistant Prostate Cancer to Bone Treated With Either an Antimicrotubule Directed Agent or Androgen Receptor (AR)-Directed Therapies
Status: Enrolling
Updated: 4/25/2018
University of Wisconsin Carbone Cancer Center
mi
from
Madison, WI
Click here to add this to my saved trials
Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in a Safety Net: Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Status: Enrolling
Updated:  4/25/2018
Parkland Health and Hospital System
mi
from
Dallas, TX
Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Parkland-UT Southwestern PROSPR Center: Colon Cancer Screening in a Safety Net: Comparative Effectiveness of FIT, Colonoscopy, & Usual Care Screening Strategies
Status: Enrolling
Updated: 4/25/2018
Parkland Health and Hospital System
mi
from
Dallas, TX
Click here to add this to my saved trials
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection
Status: Enrolling
Updated:  4/25/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection
Randomized, Placebo-Controlled, Phase 2 Study Of Induction Chemotherapy With Cisplatin/Carboplatin, And Docetaxel With Or Without Erlotinib In Patients With Head And Neck Squamous Cell Carcinomas Amenable For Surgical Resection
Status: Enrolling
Updated: 4/25/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Randomized, Double Blinded Placebo-Controlled Study of Glutamine in Patients With Oral Mucositis on an mTOR Inhibitor-based Regimen or Esophagitis on a Regimen Receiving Radiation to the Esophagus
Status: Enrolling
Updated:  4/25/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Randomized Trial of Glutamine in Patients With Mucositis or Esophagitis
Randomized, Double Blinded Placebo-Controlled Study of Glutamine in Patients With Oral Mucositis on an mTOR Inhibitor-based Regimen or Esophagitis on a Regimen Receiving Radiation to the Esophagus
Status: Enrolling
Updated: 4/25/2018
University of Texas M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memoral Sloan Kettering Basking Ridge
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Monmouth
mi
from
Middletown, NJ
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Mirena® IUD's Effect on Fallopian Tube Fimbriae and Ovarian Cortical Inclusion Cyst Cell Proliferation
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Rockville Centre
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Status: Enrolling
Updated:  4/25/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors
Status: Enrolling
Updated: 4/25/2018
Memorial Sloan Kettering Cancer Center
mi
from
New York, NY
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
Gabrail Cancer Center Research LLC
mi
from
Canton, OH
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated:  4/25/2018
The Mayo Clinic
mi
from
Rochester, MN
A Study of SC-007 in Subjects With Advanced Cancer
An Open Label Study of SC-007 in Subjects With Advanced Cancer
Status: Enrolling
Updated: 4/25/2018
The Mayo Clinic
mi
from
Rochester, MN
Click here to add this to my saved trials